Facial Filler Complications.
The use of facial fillers has greatly expanded over the past several years. Along with increased use comes a rise in documented complications, ranging from poor cosmetic result to nodules, granulomas, necrosis, and blindness. Awareness of the potential types of complications and options for management, in addition to the underlying facial anatomy, are imperative to delivering the best patient care. This article defines the complications and how to treat them and provides suggestions to avoid serious adverse outcomes.
Duke University Medical Center, Durham, NC, USA. Electronic address: Julie.woodward@duke.edu.
Julie
J
Woodward
Duke University Medical Center, Durham, NC, USA.
Tanya
T
Khan
Duke University Medical Center, Coral Gables, FL, USA.
John
J
Martin
D001672:Biocompatible Materials / Q000008:administration & dosage / Q000009:adverse effects*; D018441:Biofilms; D003357:Cosmetic Techniques / Q000009:adverse effects*; D000067548:Dermal Fillers / Q000008:administration & dosage / Q000009:adverse effects*; D017277:Drug Approval; D005260:Female; D005500:Follow-Up Studies; D015745:Granuloma, Foreign-Body / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000009:adverse effects; D015994:Incidence; D007279:Injections, Subcutaneous; D008297:Male; D009336:Necrosis / Q000139:chemically induced / Q000473:pathology; D012060:Rejuvenation / Q000502:physiology; D018570:Risk Assessment; D012828:Silicones / Q000008:administration & dosage / Q000009:adverse effects; D012867:Skin / Q000473:pathology*; D015595:Skin Aging / Q000187:drug effects; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D001672:Biocompatible Materials; D000067548:Dermal Fillers; D012828:Silicones; D006820:Hyaluronic Acid
Biofilms; Blindness; Complications; Facial fillers; Granulomas; Hyaluronic acid; Hyaluronidase; Necrosis